Previous 10 | Next 10 |
This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarman’s regulatory 13F Form filed on 11/14/2019. Please visit our Tracking Seth Klarman’s Baupost Group Holdings...
Theravance Biopharma, Inc. (TBPH) Q3 2019 Earnings Conference Call November 5, 2019 17:00 ET Corporate Participants Jessica Stitt - Vice President, Finance and Investor Relations Rick Winningham - Chief Executive Officer Brett Haumann - Chief Medical Officer Frank Pasqualone - ...
The following slide deck was published by Theravance Biopharma, Inc. in conjunction with their 2019 Q3 earnings Read more ...
DUBLIN , Nov. 6, 2019 /PRNewswire/ -- November 6, 2019 – Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that management will participate in a corporate presentation at the 28th Annual Credit Suisse Healthcare Conference on Tuesday, November 12, 2019 , at 3:00 p.m....
Image source: The Motley Fool. Theravance Biopharma Inc (NASDAQ: TBPH) Q3 2019 Earnings Call Nov 5, 2019 , 5:00 p.m. ET Operator Continue reading
Theravance Biopharma (NASDAQ: TBPH ): Q3 GAAP EPS of -$1.05 beats by $0.03 . More news on: Theravance Biopharma, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
DUBLIN , Nov. 5, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the third quarter ended September 30, 2019 . Revenue for the third quarter of 2019 was $12.4 million . Third quarter operating l...
DUBLIN , Oct. 29, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the period ended September 30, 2019 and provide a business update after market close on Tuesday, No...
DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Oct. 21, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced that data from studies of YUPELRI ® (r...
Yesterday, investors discovered the likely reason for the strange recent weakness in Theravance ( TBPH ), despite the neutral or even good news flow: Neil Woodford has been ousted and his flagship fund - which holds the bulk of his large TBPH stake - will be liquidated by BlackRock: "bec...
News, Short Squeeze, Breakout and More Instantly...
Theravance Biopharma Inc. Company Name:
TBPH Stock Symbol:
NASDAQ Market:
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024 PR Newswire DUBLIN , April 29, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update af...
2024-04-24 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...